Command Palette

Search for a command to run...

Clinical Trials · NCT01208012

Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
ikfe-CRO GmbH
Enrollment
44
Start date
Apr 2010
Locations
1 site, Germany
Primary endpoint
The difference in increase of retinal blood flow after flicker stimulation of retinal endothelial cells
View Liraglutide compound reference